Best Online HRT Providers for Women Over 40 in 2026
By The HRT Index Editorial Team · Published 2026-05-15 · Last reviewed by editors: 2026-05-26
Editorial research — not medically reviewed by a clinician.
No active affiliate links on this page as of 2026-05-26.
By The HRT Index Editorial Team — an independent comparison resource for HRT telehealth providers
Published: · Last verified: · Next verification:
Editorial research. Not medical advice. Talk to a clinician before starting, stopping, or changing HRT. As of May 26, 2026, The HRT Index does not have active affiliate partnerships with the providers on this page. Provider links are non-affiliate editorial links. If affiliate relationships are added later, this disclosure will be updated and affected links will be labeled.
If you’re searching for the best online HRT providers for women over 40, the short answer is: it depends on three things — whether you have PPO insurance, whether you’re still getting periods, and whether you want FDA-approved or compounded medication.
Verified picks for May 26, 2026:
- Midi Health — strongest starting point if you have PPO insurance. Bills most major commercial plans for the visit. MSCP-credentialed clinicians. Typical insured cost: a standard specialty copay.
- Evernow — best for perimenopause-specific care and the lowest ongoing cost. Membership from $35/month on the annual plan; pay-per-visit virtual visits at $150 that may be insurance-eligible.
- Alloy — clearest cash-pay path with FDA-approved bioidenticals. $49 one-time consult; estradiol patch from $74.99/month; oral micronized progesterone from $23/month.
- Winona — best fit if you specifically want compounded bioidenticals and understand that compounded preparations are not FDA-approved as finished products.
We also evaluated Gennev, Hers, Pandia Health, and Wisp — covered in full below.
The FDA initiated removal of broad boxed-warning language from menopausal hormone therapy products in November 2025 and approved labeling changes for the first six products on . The old WHI-era warning script is being pulled back, label by label. The “too young for HRT” line should go with it.
If you’d rather we just pick for you, the 60-second matcher routes you to your best fit.
What You’ll Find on This Page
This is the full decision guide for women in their 40s — written specifically for the perimenopausal patient, not the postmenopausal woman the generic “best HRT” lists are actually built for. You’ll get:
- A verified comparison matrix of 8 online HRT providers across 12 decision criteria — pricing, insurance, FDA-approved vs compounded, labs, perimenopause fit, state coverage, and more
- The 90-day cost reality (because “starts at $35/month” rarely means $35/month)
- The plain-English FDA labeling update and what it actually means for your decision
- A 5-question decision tree that maps your situation to a specific provider
- A 12-question clinician checklist if you decide to talk to your own doctor first
- The red flags that mean online HRT is the wrong starting point for you specifically
Every claim is sourced. Every price has a verification date. If something is uncertain, we say so.
What We Actually Verified ()
✓ Verified
- Provider-stated pricing on public vendor pages
- Insurance posture (PPO billing, HSA/FSA, Medicare/Medicaid exclusions)
- Medication categories (FDA-approved vs compounded; estradiol forms)
- Lab and monitoring policies as stated by each provider
- Stated state availability
- Cancellation terms where published
- FDA boxed-warning status against the FDA press release
- Clinical claims against Menopause Society, ACOG, and Endocrine Society guidance
⚠ Not completed this cycle
- Full incognito checkout flow on every provider
- Real PPO coverage check through a specific plan
- ZIP-code-specific pharmacy price quotes
- Direct support-response-time tests
Where these gaps affect a recommendation, the provider review says so.
Best Online HRT Providers for Women Over 40: The 2026 Verification Matrix
Twelve criteria, eight providers, one table. All cells verified against public vendor pages on — confirm on the provider’s site before committing.
| Provider | Best for (over 40) | First-step cost | Bills PPO for visit? | Handles perimenopause? | FDA-approved formulary? | Compounded options? | Labs to start? | Testosterone? | States | Cancellation |
|---|---|---|---|---|---|---|---|---|---|---|
| Midi Health | PPO-insured + menopause-specialist care | ~$0–$50 PPO copay; $250 self-pay initial / $150 follow-up | Yes — most major PPOs | Yes | Yes — default | Not standard | No (symptom-first) | Low-dose where clinically appropriate | All 50 states | Standard medical practice |
| Evernow | Perimenopause-specific care + lowest ongoing cost | $35/mo annual ($420 upfront); $150 pay-per-visit (may be insurance-eligible) | Pay-per-visit may be covered | Yes — perimenopause-calibrated intake | Yes | Yes — also lists compounded; verify your Rx | No | Off-label, clinician-directed | All 50 states | Cancel anytime |
| Alloy | Cash-pay + FDA-approved bioidenticals + broad scope | $49 one-time consult; patch from $74.99/mo, progesterone from $23/mo | No (HSA/FSA accepted) | Yes — includes low-dose birth-control discussion | Yes — default | Not standard | No | No — Alloy does not prescribe testosterone | Supported states; verify at intake | Cancel ≥7 days before period end |
| Winona | Compounded bioidentical-focused care | Compounded cream from $89/mo; patches from $149/mo; oral progesterone from $39/mo | No (HSA/FSA accepted) | Yes | Mixed — FDA-approved + compounded | Yes — primary formulary | No labs required | Typically DHEA instead | Most states | Cancel anytime |
| Gennev | Higher-touch scheduled doctor visit + dietitian support | $250 doctor initial / $199 follow-up; $199 dietitian initial / $119 follow-up | Yes — where in-network | Yes | Yes — default | Not standard | Clinician-directed | Off-label, clinician judgment | Most states | Standard medical practice |
| Hers | Lowest-friction consumer-style intake | Oral plan from $79/mo (12-mo); patch from $134/mo (12-mo) | No (HSA/FSA accepted) | Yes — off-label at provider discretion (stated explicitly) | Yes — default | No | No | No | Most states | Cancel anytime |
| Pandia Health | Continuity + automatic medication shipment | $34.99/mo (annual); $59/mo (quarterly); $69/mo (monthly). Medication separate. | Plan-dependent | Yes | Yes — broad menu incl. Veozah, paroxetine | Not standard | No (clinician review) | No | Most states | 30 days’ written notice; $150 minimum may apply |
| Wisp | Vaginal estrogen / GSM at lowest cost | Vaginal estradiol cream from $20; menopause consult $99 (includes 3-month care-team access) | No (HSA/FSA accepted) | Yes (especially GSM) | Yes — default | No | No | No | Most states | Per-product |
About compounded medications: Compounded medications are not FDA-approved as finished products. Per the FDA, the agency does not have evidence that compounded bioidentical hormones are safer or more effective than FDA-approved hormone therapy. Per ACOG, compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist.
About testosterone for women: Testosterone is a Schedule III controlled substance in the U.S. There is no FDA-approved testosterone product specifically for menopausal symptoms in women. Where prescribed, it is off-label and clinician-directed.
Definitions you’ll need
Estradiol: the main estrogen your ovaries make — available as patch, pill, gel/spray, or vaginal cream.
Micronized progesterone: the bioidentical form of progesterone. Women with a uterus need this alongside systemic estrogen.
Bioidentical: same chemical structure as the hormone your body makes. FDA-approved bioidenticals exist (estradiol patches, Prometrium). Compounded bioidentical preparations are not FDA-approved as finished products.
MSCP: Menopause Society Certified Practitioner — a clinician with focused training in menopause management.
Perimenopause: the 4-to-10-year transition before your final period, usually starting in the late 30s or 40s.
Match Yourself to a Provider in 60 Seconds
We built a 5-question matcher specifically for women in their 40s. It maps your situation to a specific provider, gives you the reasoning, and estimates the first 90-day cost. Free. No email required.
- Are you still having periods, even irregular ones?
- Do you want to use commercial insurance for the visit?
- Has a doctor told you your “labs are normal” but you still feel terrible?
- What matters more — lowest price, specialist credentials, fastest start, or comprehensive care?
- What’s your dominant symptom right now?
“You’re Too Young for HRT” — What Actually Changed in Late 2025
The short answer: The FDA initiated removal of the broad boxed-warning language from menopausal hormone therapy products in November 2025 and approved labeling changes for the first six products on . The cardiovascular, breast-cancer, and probable-dementia statements were taken out of those labels. The boxed warning related to endometrial cancer for systemic estrogen-alone products in women with a uterus is not being removed.
That class-wide warning is the single biggest reason women in their 40s have been told “you’re too young” for two decades. The warning is on its way out. The reason should be too.
The backstory in plain English
In 2002, the Women’s Health Initiative (WHI) announced that women on hormone therapy had higher rates of heart disease and breast cancer. What got lost in the press release:
- The average woman in the study was 63 years old. Most women starting HRT today are 45 to 55.
- The risks were reported as relative, not absolute. A “26% increase in breast cancer risk” was about 8 extra cases per 10,000 women per year — and only in women on combined estrogen + a specific synthetic progestin (medroxyprogesterone acetate), not what online providers in our cohort prescribe today.
- The study used oral conjugated equine estrogen. Transdermal estradiol (the patch) has a different and lower clot-risk profile.
- For women starting HRT within 10 years of their final period, the risk-benefit picture is meaningfully different from the WHI’s 2002 framing.
The Menopause Society — the biggest U.S. clinical body in this field — has held a position supporting HRT for women within 10 years of menopause onset for nearly a decade. The training gap in primary care never caught up. That’s why your doctor probably hasn’t read the update.
So no — you are very likely not too young. If you’re in your 40s and symptomatic, you’re inside the window most current guidance considers the best time to start.
Perimenopause Is Not Menopause. That Distinction Decides Your Provider.
The short answer:Perimenopause is the transition itself — the 4-to-10-year stretch before your final period when estrogen and progesterone get erratic before they decline. Most women in their 40s are in perimenopause, not menopause. Many telehealth providers are built for postmenopausal women and treat perimenopausal patients like they don’t fit. The providers worth your time are the ones built for the transition itself.
Why your labs probably came back “normal”
In perimenopause, your hormones fluctuate hour to hour. A single blood draw at a single moment is a snapshot of one moment. If your estradiol happened to be on the upswing that morning, your lab number looks fine. The next afternoon it could be in the basement. The Menopause Society’s current guidance does not require routine hormone-level testing to initiate HRT in a healthy patient whose symptom pattern and age are consistent with perimenopause.
What “cyclic progesterone” means and why it matters in your 40s
If you’re still getting periods, you might still be ovulating sometimes. Adding continuous progesterone every day — the standard postmenopausal protocol — can fight with that. Cyclic progesterone means you take progesterone for part of the month (usually 12–14 days), not every day. Evernow and Midi can adjust protocols to your situation; Alloy discusses low-dose birth-control options alongside HRT for still-cycling women.
Where each provider lands on perimenopause specifically
| Provider | Explicitly handles perimenopause? | Asks about cycle status? | Off-label disclosure? |
|---|---|---|---|
| Midi Health | Yes — perimenopause is central to the brand | Yes | Discussed at clinician visit |
| Evernow | Yes — perimenopause-calibrated intake | Yes | Discussed |
| Alloy | Yes — includes low-dose birth-control discussion | Yes | Discussed |
| Gennev | Yes — menopause-trained physician model | Yes | Discussed |
| Hers | Yes — but HRT for perimenopause is off-label, prescribed at provider discretion (per Hers’ own page) | Yes | Yes, stated explicitly on menopause page |
| Pandia Health | Yes | Yes | Discussed |
| Winona | Yes — bioidentical-HRT framing covers both | Yes | Discussed |
| Wisp | Yes (especially for GSM symptoms) | Yes | Discussed |
Where you actually are on the curve
- Early perimenopause: Periods are still mostly regular, but cycle length is shifting. PMS is worse. Sleep is starting to crack. Often late 30s to mid-40s.
- Late perimenopause: Periods are skipping months. Hot flashes show up. Sleep is broken. This is where most 40s women seeking online HRT land.
- Menopause: 12 consecutive months with no period. Average age in the U.S. is 51.
- Postmenopause: Everything after the 12-month mark.
How to Choose: A 5-Question Decision Tree for Women in Their 40s
Q1: Are you still getting periods, even irregular ones?
- Yes → You need a provider that does perimenopause prescribing. Top picks: Evernow (perimenopause-calibrated intake), Midi (clinical depth), Alloy (includes low-dose birth-control discussion).
- No, periods stopped 12+ months ago → You’re postmenopausal. All eight providers are reasonable starting points.
- Spotting only / not sure → Start with Midi or Gennev — both have the clinical depth to figure out where you actually are. Unexplained bleeding always warrants evaluation before any prescription.
Q2: Do you want to use insurance for the visit?
This is the single biggest split in the cohort. Yes → Midi Health (most major PPOs) or Gennev (where in-network). No → Alloy (transparent cash pricing), Evernow (cheapest ongoing), or Hers (lowest friction).
Q3: What’s your dominant symptom?
- Hot flashes + night sweats wrecking sleep → Systemic estradiol is the most-studied intervention. Midi, Alloy, Evernow, Gennev all prescribe it.
- Vaginal dryness, painful sex, recurrent UTI → Genitourinary syndrome of menopause (GSM). Wisp has the lowest-cost path; Alloy, Pandia, Midi all prescribe it too.
- Brain fog, mood, sleep — no major hot flashes → Often perimenopause. Evernow is built for this. Midi can also handle it.
- All of the above → Alloy for the broadest scope, or Midi for the deepest clinical bench.
Q4: What can you afford monthly, all-in?
- Under $80/month → Evernow annual plan (~$35/mo amortized + ~$30/mo medication ≈ ~$65/mo total), or Wisp for vaginal-only.
- $80–$150/month → Alloy ($49 consult amortized + $75/mo patch + $23/mo progesterone ≈ ~$100/mo).
- $150–$250/month → Winona compounded, or Pandia with medication.
- Insurance-only, no cash tolerance → Midi with PPO is the most reliable answer.
Q5: How much clinician relationship do you want?
- High — I want a real doctor who follows me over time → Gennev (scheduled visits + dietitian), Midi (MSCP credentials), or Alloy (unlimited messaging).
- Async/low — I want messaging and to be left alone otherwise → Evernow (async is the default), Hers (consumer-app feel).
- Continuity — I just want my refills to show up → Pandia Health (automatic medication shipment).
Which Online HRT Provider Is Best With Insurance vs Paying Cash?
Best with PPO insurance
Midi Health is the most legible insurance-first option. Most patients with PPO coverage pay approximately $0–$50 out-of-pocket per visit. Self-pay is$250 initial / $150 follow-up. HMO plans are typically out-of-network.
Gennev accepts insurance where in-network. Self-pay is $250 initial / $199 follow-up for the doctor.
Evernow offers a pay-per-visit virtual visit at $150 self-pay that may be eligible for commercial insurance coverage through major plans — verify your specific plan before booking.
Best without insurance (cash-pay)
- Alloy — clearest upfront pricing. $49 one-time consult + medication at published rates.
- Evernow — lowest ongoing cost. $35/mo on the annual plan + medication ($20–$60/mo).
- Hers — lowest entry friction. Oral plan from $79/mo on a 12-month plan.
- Wisp — $99 menopause consult includes 3-month care-team access; lowest-cost path for vaginal estrogen.
- Winona — best for the patient who specifically wants compounded preparations.
Medicare and Medicaid
Midi does not accept Medicaid or Medi-Cal patients— even as self-pay. Midi accepts Medicare beneficiaries on a self-pay basis only; Medicare-related claims cannot be submitted. Other providers’ Medicare and Medicaid policies vary; verify with each one before you commit. For many patients on these plans, an in-person clinician through your existing benefits is the cleaner first step.
The 8 Best Online HRT Providers for Women Over 40, Reviewed
Eight providers, evaluated against twelve criteria specifically weighted for the over-40 perimenopausal cohort. Awards reflect editorial judgment against our methodology, not affiliate priority.
1. Midi Health — Best Overall for Women With PPO Insurance
What you actually get
Midi operates as a clinical practice, not a subscription product. You book a visit. The clinician — typically a nurse practitioner or physician with menopause-specific training — takes a real history. They prescribe FDA-approved estradiol (patch, oral, or vaginal) plus micronized progesterone if you have a uterus and use systemic estrogen. Low-dose testosterone is available where clinically appropriate (off-label). Compounded preparations are not part of the standard offering.
Midi is in-network with most major PPO plans — Aetna, Blue Cross plans, UnitedHealthcare, Cigna in many markets — and patients typically owe a standard specialty copay.
Verified pricing ()
- Most patients with PPO insurance pay approximately $0–$50 out-of-pocket per visit, depending on plan benefits.
- Self-pay initial visit: $250. Follow-up: $150.
- Medications and labs billed separately through your pharmacy benefit and lab provider.
2. Evernow — Best for Perimenopause and Lowest-Cost Ongoing Care
What you actually get
Evernow’s model has two paths: an asynchronous membership ($35–$49/mo) where you complete intake and the clinician prescribes through secure messaging, and a pay-per-visit virtual visit ($150 self-pay, may be insurance-eligible). Medications are an additional $20–$60/month and can go to your local pharmacy or ship to your door.
Evernow’s public hormone-therapy page lists estrogen patches, pills, vaginal estrogen tablets, progesterone, and compounded bioidentical formulations. If FDA-approved-only matters to you, say so explicitly before any prescription is finalized.
Verified pricing ()
- Membership: $35/mo annual ($420 paid upfront) / $43/mo quarterly ($129) / $49/mo monthly
- Pay-per-visit virtual: $150 self-pay; insurance eligibility varies
- Medications: $20–$60/month additional
3. Alloy — Best Cash-Pay Option for FDA-Approved Bioidenticals
What you actually get
Alloy’s pricing includes unlimited messaging and telemedicine consultations as needed. The formulary is broad: estradiol (patch, oral, vaginal), oral micronized progesterone, vaginal estrogen for GSM, low-dose birth-control discussion for still-cycling women, and adjacent non-hormonal prescriptions for sleep, libido, hair, and skin. Clinical leadership includes physicians with the MSCP credential. The prescribing default is FDA-approved bioidentical hormones, not compounded.
One thing Alloy does not do: prescribe testosterone.Per Alloy’s own published clinical position, their physicians currently do not prescribe testosterone, citing the lack of an FDA-approved product for women, the controlled-substance status, and the need for frequent level checks.
Verified pricing ()
- One-time consultation: $49.95
- Estradiol patch: $74.99/month (billed quarterly as $224/quarter)
- Oral estradiol: from $39.99/month
- Oral micronized progesterone: from $23/month
- Estradiol gel/spray (Evamist): from $69.99/month
- HSA and FSA accepted. Subscription auto-renews; cancel ≥7 days before period end.
Alloy holds a 4.4/5 Trustpilot rating across more than 2,100 reviews as of early 2026, with reviewers frequently citing the experience of being taken seriously by a menopause-specialist clinician. (Editorial observation from public review aggregates; not a claim about medical outcomes.)
4. Winona — Best for Compounded Bioidentical Options (Read the Fine Print)
The FDA-approved vs compounded distinction (you have to understand this)
Per the FDA, the agency does not have evidence that compounded “bioidentical” hormones are safer or more effective than FDA-approved hormone therapy. Per ACOG, compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist. That doesn’t mean compounded is bad — it means it’s not the default first answer for most women. For a woman in her 40s starting HRT for typical perimenopause symptoms, the FDA-approved patch + oral progesterone protocol at Midi or Alloy is the more conservative choice.
Verified pricing ()
- Compounded estrogen + progesterone body cream: from $89/month
- Estradiol patches: from $149/month
- Oral estradiol tablets: from $54/month
- Oral progesterone capsules: from $39/month
- DHEA: $27 per 3-month supply
- HSA/FSA accepted; no direct insurance billing. No labs required to start.
5. Gennev — Best for Higher-Touch Doctor Visits + Insurance
What you actually get
Gennev’s clinical model centers on a real doctor visit, not an asynchronous intake. The initial visit is a scheduled video appointment with a menopause-trained physician. Follow-ups are also scheduled visits. A registered dietitian add-on is available. The formulary is FDA-approved estradiol (patch, oral, vaginal) and micronized progesterone, plus non-hormonal options where appropriate.
Verified pricing ()
- Doctor initial visit (self-pay): $250
- Doctor follow-up (self-pay): $199
- Dietitian initial visit: $199
- Dietitian follow-up: $119
- Insurance accepted where in-network; verify your specific plan.
6. Hers — Best for Low-Friction Consumer-Style Intake
What you actually get
Hers (the women’s-health arm of Hims & Hers Health) launched its menopause and perimenopause specialty in October 2025. The intake is short; the eligible patient can be prescribed FDA-approved estradiol (oral, patch, or vaginal cream) plus oral micronized progesterone if she has a uterus. The perimenopause off-label note is important and Hers states it themselves — most online providers prescribing for perimenopause are doing so off-label, but Hers is the most explicit about saying so.
Verified pricing ()
- Oral medication plan: from $79/month on a 12-month plan
- Patch plan: from $134/month on a 12-month plan
- Pricing shown during intake; final cost may vary. HSA/FSA accepted.
7. Pandia Health — Best for Continuity and Refill Reliability
What you actually get
Pandia Health is physician-founded with an explicit operational focus on women historically under-served in menopause care, particularly women of color. Membership covers ongoing clinician access; medications ship automatically. The formulary is broad: FDA-approved estradiol (patch, oral, vaginal), micronized progesterone, vaginal estrogen creams and suppositories, the vaginal ring, plus non-hormonal options including paroxetine and fezolinetant (Veozah).
Verified pricing ()
- Membership: $34.99/month annual / $59/month quarterly / $69/month monthly
- Medication is not included — billed separately; often covered by commercial insurance at pharmacy
- HSA/FSA accepted
- Cancellation requires 30 days’ written notice. If you cancel before total payments reach $150, Pandia’s telemedicine consent states you may be charged the difference.
8. Wisp — Best for Vaginal Estrogen and Targeted GSM Care
What you actually get
Wisp’s clinical model is narrow on purpose. Originally a women’s sexual-health platform, they’ve extended into menopause with a focused offering: vaginal estrogen products (cream, tablet), a menopause consult that can lead to systemic HRT prescriptions where appropriate, and ongoing access to the care team.
Verified pricing ()
- Estradiol vaginal cream: starting at $20 through partner pharmacy where available. 90-day quantity and refill cadence require verification at checkout.
- Menopause consult: $99 (includes consult, follow-ups, and 3-month care-team access)
- Medications dispensed via partner pharmacy or local pharmacy pickup. HSA/FSA accepted.
What Online HRT Actually Costs in 2026: The 90-Day Reality Check
Real all-in cost for online HRT for a woman in her 40s in 2026 ranges from roughly $65/month (Evernow annual + generic estradiol) to over $200/month (Winona compounded creams). Insurance-billed care through Midi is typically $0–$50 per visitplus medication through your pharmacy benefit. The “starts at $35” headlines almost never reflect the all-in number.
| Provider | Visit / consult / membership (90 days) | Estimated medication (90 days) | 90-day cash (first 90 days) |
|---|---|---|---|
| Midi (insured, PPO) | ~$0–$150 (1–2 visits at copay) | ~$30–$90 (covered by pharmacy benefit) | ~$30–$240 |
| Midi (self-pay) | $250 initial + $150 follow-up = $400 | ~$60–$150 (cash at retail) | ~$460–$550 |
| Evernow (annual plan) | $420 paid upfront (amortizes to $35/mo over 12 months) | $60–$180 ($20–$60/mo × 3) | ~$480–$600 |
| Evernow (3-month plan) | $129 paid upfront ($43/mo equivalent) | $60–$180 | ~$189–$309 |
| Alloy (cash-pay) | $49 one-time consult | Patch × 3 ($224) + progesterone × 3 ($69) = $293 | ~$342 |
| Winona | $0 (subscription is medication) | Compounded cream × 3 ($267) OR patch × 3 ($447) + progesterone × 3 ($117) | ~$267–$564 |
| Gennev (self-pay) | $250 initial + $199 follow-up = $449 | ~$60–$150 (cash at retail) | ~$510–$600 |
| Hers (12-mo oral plan) | $0 (bundled into plan) | $79 × 3 = $237 | ~$237 |
| Pandia (annual plan) | ~$105 ($34.99/mo × 3) | ~$60–$150 (insurance or cash at pharmacy) | ~$165–$255 |
| Wisp (vaginal-only) | $99 consult (covers 3 months) | $20 starting; 90-day refill qty varies | ~$120–$200 |
Caveats: Numbers assume an uncomplicated case with no labs ordered. Insurance changes the math substantially. Evernow annual plan requires the full $420 upfront on day 1. Hers patch plan would shift the number higher.
Estimate Your Specific 90-Day Cost in the Matcher →FDA-Approved vs Compounded HRT — What the Labels Actually Mean
The short answer: FDA-approved HRT products have been evaluated by the FDA for safety and effectiveness. Compounded HRT preparations are mixed by a compounding pharmacy and are not FDA-approved as finished products. Per ACOG, compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist. For most women in their 40s starting HRT for typical perimenopause symptoms, the FDA-approved path is the more conservative first answer.
FDA-approved bioidentical hormone products
- Estradiol patches: Climara, Vivelle-Dot, Minivelle, generic estradiol patch
- Oral estradiol tablets: Estrace, generic
- Estradiol gels and sprays: EstroGel, Divigel, Evamist
- Vaginal estradiol: Estrace cream, Vagifem/Yuvafem tablets, Estring ring
- Combined estradiol + progesterone capsule: Bijuva (FDA-approved 2018)
- Oral micronized progesterone: Prometrium, generic
What “compounded” actually means
A compounding pharmacy mixes a custom preparation based on a clinician’s prescription. Compounding is legal and necessary for many medications. But:
- Compounded preparations are not FDA-approved as finished products. The FDA does not verify safety, effectiveness, or quality of the final compounded product before marketing.
- Compounded products may use unstudied ingredients or ratios. Estriol is the most common example — it’s not in any FDA-approved product.
- Dose consistency varies pharmacy-to-pharmacy. Two compounded creams at the same “dose” may absorb differently.
What to never accept from any provider
- “FDA-approved compounded HRT” — these phrases together are a red flag. Compounded final products are not FDA-approved.
- “Clinically proven” claims for a compounded formulation — the studies of FDA-approved bioidenticals don’t automatically transfer to a compounded version.
- “Same active ingredient as the brand” used to imply compounded equals FDA-approved — they’re not the same product in regulatory terms.
Is Online HRT Safe? What the FDA Labeling Update Actually Changed
The short answer:Online HRT prescribed by a licensed clinician can use the same FDA-approved medications an in-person clinician would prescribe. The FDA’s removal of the cardiovascular, breast-cancer, and probable-dementia warnings from the first six menopausal hormone therapy product labels (initiated November 2025, first batch approved ) reflects a reassessment that menopause-society guidance has supported for nearly a decade. The boxed warning for endometrial cancer in women with a uterus using systemic estrogen-alone products is not being removed.
The first six products with updated labels
- Progesterone capsules 100mg and 200mg (Prometrium)
- Estradiol gel (Divigel)
- Synthetic conjugated estrogens A tablets (Cenestin)
- Synthetic conjugated estrogens B tablets (Enjuvia)
- Estradiol vaginal system (Estring)
- Estradiol and progesterone capsules (Bijuva)
The rest are expected to follow through 2026 as additional drug companies’ labeling changes are approved.
Green flags when picking an online provider
- Licensed clinician reviews your medical history — not just a questionnaire that auto-prescribes
- Prescription required — no “FDA-approved supplements that work like HRT”
- Provider asks about uterus status, unexplained bleeding, clot history, cancer history, cardiovascular history, migraine with aura, smoking, medications, and pregnancy possibility
- Provider explains FDA-approved vs compounded options clearly
- Follow-up is built in — not just a one-and-done prescription
- Pricing and cancellation terms are visible before you commit
Red flags
- “No prescription needed”
- “Guaranteed hormone balance”
- “FDA-approved compounded HRT” (these phrases don’t go together)
- Testosterone pushed as a first-line treatment for energy, weight, or mood
- No clinician review — just a questionnaire that auto-prescribes
- No contraindication screening
- Vague pharmacy sourcing
- No cancellation terms published
Do You Need Lab Tests Before Starting HRT Online?
The short answer: No, not in most cases. Current Menopause Society guidance does not require routine hormone-level testing to initiate HRT in a healthy patient whose symptom pattern and age are consistent with perimenopause or menopause. Hormone levels fluctuate substantially in perimenopause; a single blood draw is a poor diagnostic.
When labs probably won’t change the answer
- Typical hot flashes and night sweats
- Classic perimenopause symptom pattern (irregular cycles, sleep disruption, mood shifts)
- Symptoms clearly linked to a hormonal pattern your clinician recognizes
When labs (or in-person care) may matter
- Premature menopause concerns (under 40)
- Possible pregnancy
- Unexplained vaginal bleeding
- Thyroid-like symptoms
- Complex cardiovascular, clot, or cancer history
- Testosterone or other off-label hormone discussions
Where each provider lands on labs
- No labs to start (symptom-first): Winona, Evernow, Alloy, Hers, Wisp, Pandia
- Labs when clinically indicated: Midi, Gennev
A provider that always orders labs is not necessarily safer. A provider that neverorders them is not following guidance either. The right answer is “when they change the decision.”
When Online HRT Is the Wrong Starting Point
If any of the following apply to you, you need an in-person clinician evaluation before any video visit:
- Unexplained vaginal bleeding (especially postmenopausal — this needs evaluation, not a prescription)
- Current or past estrogen-sensitive cancer (breast, certain endometrial)
- Recent stroke, heart attack, or blood clot (VTE, PE, DVT) within the past 12 months
- Known high-risk clotting disorder (Factor V Leiden, antiphospholipid syndrome)
- Possible pregnancy
- Severe uncontrolled high blood pressure
- Active liver disease
- Migraine with aura (relative contraindication for oral estrogen specifically; transdermal may still be an option after clinician evaluation)
- Symptoms that may not be hormonal (sudden severe symptoms, weight loss, persistent fatigue with abnormal labs)
But here’s the pivot: for the vast majority of women in their 40s with typical perimenopause symptoms and no contraindications, the online HRT providers above are often the best available option. Most local primary-care clinicians have less than 20 hours of menopause training in residency. The clinician with the most menopause expertise within reach for most women in this country is online, not down the street.
What Happens After You Choose a Provider?
- 1Step 1 — IntakeYou fill out a detailed questionnaire about symptoms, age, period status, medical history, medications, uterus status, contraindications, and goals. Usually 10–20 minutes.
- 2Step 2 — Clinician reviewAsynchronous review (Evernow, Winona, parts of Hers) where the clinician reads your intake and prescribes in writing; or a scheduled video visit (Midi, Gennev, Evernow virtual visit); or a hybrid (Alloy, Pandia).
- 3Step 3 — Prescription decisionIf you're a candidate, the clinician prescribes. If not, they explain why and (good providers) offer alternatives. A clinician should not prescribe HRT to a woman with an active contraindication.
- 4Step 4 — Medication fulfillmentDirect shipping from a partner pharmacy (Winona, Alloy patches, Evernow, Pandia) or local pharmacy pickup (Midi, Gennev, Wisp, parts of Evernow). Shipping vs local pickup affects timing and how insurance interacts with medication cost.
- 5Step 5 — Follow-upMost providers re-check in at 4–8 weeks. You report on symptom improvement, side effects, and whether the dose feels right. Adjustments are common — almost no one lands on the right dose on the first try.
- 6Step 6 — Ongoing reassessmentThe Menopause Society's 2022 position statement recommends individualized care with periodic reassessment — not a fixed 'stop at age X' rule. The conversation about whether to continue HRT, change formulation, or step down should happen with your clinician.
What to Ask Before You Choose an Online HRT Provider
A 12-question checklist for women who want to walk into their first visit prepared. Save it. Print it. Bring it.
How We Ranked These Providers (and What We Weighted)
This page is editorial research, not affiliate-payout sorting. Here are the actual weights we used.
| Factor | Weight | Why it matters for women over 40 |
|---|---|---|
| Medical legitimacy and prescription process | Required gate | HRT is prescription medical care — no licensed clinician = not on this list |
| Perimenopause / over-40 fit | 20% | This page exists because most “best HRT” lists are written for postmenopausal women |
| FDA-approved vs compounded clarity | 20% | A provider that blurs this distinction is misleading patients |
| Cost transparency (real 90-day number) | 15% | “$35/mo” headlines hide medication, follow-up, and pharmacy costs |
| Insurance / cash-pay fit | 15% | The right provider changes based on payment model |
| Follow-up and ongoing support | 10% | HRT almost always needs dose adjustment in the first 6 months |
| Lab/testing approach | 10% | Labs when they change the decision; not as a gatekeeping fee |
| State availability | 5% | A perfect provider is useless if unavailable in your state |
| Cancellation / subscription friction | 5% | 30-day notice clauses, auto-renew terms, and minimum-charge clauses are real |
What we explicitly did NOT use as a ranking factor:Trustpilot star count alone (manipulable, doesn’t measure clinical quality); marketing spend or brand recognition; affiliate payout rates (no active relationships as of May 26, 2026); founder background alone.
Frequently Asked Questions
Can women over 40 get HRT online?
Yes, in most cases. If you’re a U.S. resident in your 40s with typical perimenopause or menopause symptoms and no major contraindications, a licensed clinician at any of the eight providers above can prescribe HRT after a legitimate clinical encounter. The clinical bar is the same as in-person care: a real history, screening for contraindications, and follow-up.
What is the best online HRT provider for women over 40?
It depends on your situation. Midi Health is the strongest starting point if you have PPO insurance. Evernow is the best for perimenopause specifically and the lowest ongoing cost. Alloy is the best cash-pay option with FDA-approved bioidenticals. Winona is the best fit only if you specifically want compounded bioidenticals and understand they’re not FDA-approved as finished products.
Can I get HRT online if I’m still having periods?
Yes. Several providers explicitly handle perimenopause prescribing — Evernow has a perimenopause-calibrated intake, Alloy can discuss low-dose birth control alongside HRT, and Midi has the clinical depth to evaluate where you actually are in the transition. Hers states directly on its menopause page that HRT for perimenopause is off-label and prescribed at provider discretion.
Is 41, 43, 45, or 47 too young for HRT?
No — 41, 43, 45, or 47 is not automatically too young. Current Menopause Society guidance supports individualized HRT for appropriately selected women with bothersome menopausal symptoms who are under 60 or within 10 years of menopause onset and have no contraindications. The FDA initiated removal of broad boxed-warning language on menopausal hormone therapy in November 2025 and approved the first six updated product labels on February 12, 2026.
How much does online HRT cost per month for women in their 40s?
All-in monthly cost ranges from roughly $65/month (Evernow annual + generic estradiol, after the upfront payment amortizes) to over $200/month (Winona compounded creams). Insurance-billed visits through Midi typically cost $0–$50 per visit with PPO coverage, with medication run through your pharmacy benefit separately. Headline “starts at $35/month” prices don’t include medication.
Do I need lab tests to start HRT online?
Usually not. The Menopause Society does not require routine hormone-level testing to initiate HRT in a healthy patient with a symptom pattern consistent with perimenopause or menopause. Hormone levels fluctuate hour to hour in perimenopause, making a single blood draw a poor diagnostic. Some clinicians prefer baseline cardiovascular and metabolic labs for risk characterization.
What is the difference between bioidentical HRT and compounded HRT?
“Bioidentical” means a hormone has the same chemical structure as the one your body produces. 17-beta-estradiol and micronized progesterone are both available as FDA-approved finished products (Estrace, Prometrium, Bijuva). Compounded bioidentical preparations are mixed by a compounding pharmacy and are not FDA-approved as finished products. The two are frequently conflated in marketing copy; they are not the same in regulatory terms.
Will my insurance cover online HRT?
For the clinical visit: most online HRT providers do not bill commercial insurance. Midi Health is the main exception, in-network with most major PPO plans. Gennev also accepts insurance where in-network. Evernow’s pay-per-visit virtual visits may be insurance-eligible. For the medication: most FDA-approved estradiol and progesterone prescriptions can be filled at a retail pharmacy through your pharmacy benefit regardless of which telehealth provider prescribed them.
How fast will I feel better on HRT?
Most women notice some improvement in hot flashes and night sweats within 2 to 4 weeks of starting an adequate dose, with continued improvement over 2 to 3 months. Sleep often improves on a similar timeline. Mood, cognition, joint comfort, and energy frequently take 3 to 6 months and may require dose adjustment. Vaginal symptoms treated with local vaginal estrogen typically improve within 4 to 8 weeks.
Can I get testosterone for women through an online HRT provider?
Some providers prescribe low-dose testosterone for women when clinically appropriate — most commonly for distressing low sexual desire (HSDD) that persists after estrogen has been optimized. Testosterone for women in the United States remains off-label — there is no FDA-approved testosterone product specifically for women. Testosterone is also a Schedule III controlled substance. Alloy specifically does not prescribe testosterone. Midi prescribes low-dose testosterone where clinically appropriate.
What if I have a family history of breast cancer?
Family history of breast cancer is a meaningful factor in the HRT decision but is not an automatic contraindication. The decision depends on which relatives, what age they were diagnosed, whether genetic testing has been done (BRCA1/BRCA2 status), and your personal risk profile. This is a conversation for a real clinician with your full history — not a checkbox on an intake form. If your family history is significant, an in-person evaluation with an MSCP-credentialed menopause specialist or a high-risk breast clinic is the right first step.
How long can I stay on HRT?
Current Menopause Society guidance has moved away from the older “shortest duration, lowest dose” rule toward an individualized model in which the decision to continue is reviewed periodically with your clinician based on ongoing symptoms, benefits (including bone protection), risks, and your preferences. There’s no fixed external deadline. For many women the right answer is several years; for some it’s considerably longer.
Still Not Sure Which HRT Program Is Right for You?
Take our free 60-second matching quiz. It asks 5 questions, maps your situation to one of the 8 providers above, gives you the reasoning, and estimates your first 90-day cost.
No email required to see the result.
Find My HRT Path →What This Report Is, and What It Is Not
This report is editorial research from The HRT Index — an independent comparison resource for HRT telehealth providers. It is the product of careful reading of public clinical materials, vendor documentation, peer-reviewed menopause-management literature, and current Menopause Society, ACOG, FDA, and International Menopause Society guidance.
This report is not medical advice. The right HRT decision for you depends on your history, your symptoms, your contraindications, and your preferences. Nothing here is a substitute for a real clinical encounter with a licensed clinician who knows you.
The HRT Index is independent. As of , we do not have active affiliate partnerships with the providers on this page. Provider links are non-affiliate editorial links. If affiliate relationships are added later, affected links will be labeled near the link and disclosed above the fold. Rankings are determined by editorial judgment against the published methodology, not by commercial relationships.
Spot something to correct? Email corrections@thehrtindex.com. Corrections are logged at /corrections/.
Sources
- FDA. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. .
- HHS. Fact Sheet: FDA Initiates Removal of Black Box Warnings from Menopausal HRT Products. November 2025.
- The Menopause Society. 2022 Hormone Therapy Position Statement. menopause.org.
- ACOG. Compounded Bioidentical Menopausal Hormone Therapy (Clinical Consensus). 2023.
- FDA. Menopause and Hormone Replacement Therapy. fda.gov.
- Alloy. Our clinical position on testosterone. myalloy.com. Verified May 2026.
- Midi Health. Pricing & Insurance. joinmidi.com/pricing-insurance. Verified May 2026.
- Evernow. Hormone Replacement Therapy. evernow.com. Verified May 2026.
- Pandia Health. Telemedicine Consent. pandiahealth.com/telemedicine-consent. Verified May 2026.
- Gennev. Insurance & Pricing. gennev.com/patients/insurance-pricing. Verified May 2026.
- Hers. Blog: Does Insurance Cover HRT? forhers.com. Verified May 2026.
- OB/GYN residency menopause curriculum survey: PMID 23733037. PubMed.
- Menopause Society Position Statement 2022: PMID 35797481. PubMed.
- Transdermal estradiol and clot risk profile: pmc.ncbi.nlm.nih.gov/articles/PMC12565450/.
- Oprah Winfrey quote: Oprah Daily “The Life You Want” menopause conversation, 2023.
The HRT Index — Related Guides